Tema ETF Trust has recently submitted its NPORT-P report, providing a snapshot of its financial health as of August 31, 2026. The filing, dated October 30, 2026, reveals that the fund holds total assets of approximately $7.66 million and net assets of about $7.66 million. This update is significant for the company as it underscores its commitment to transparency and regulatory compliance in the investment sector.

The Tema ETF Trust is an investment entity incorporated in Delaware. It is primarily focused on managing exchange-traded funds (ETFs), specifically in the healthcare sector. The trust operates under the SEC file number 811-23823 and has a registered address at 1919 M Street, N.W., Suite 700, Washington, DC.

The NPORT-P filing indicates that the fund has not reported any liabilities, which positions it favorably in terms of financial stability. The total assets reported are $7,664,544, with net assets slightly lower at $7,661,933. The fund's holdings include various healthcare-related companies, reflecting its strategic focus on this sector.

According to the filing, some of the notable investments include Illumina Inc, Cardinal Health Inc, and Vertex Pharmaceuticals Inc, among others. These companies represent a diverse array of healthcare technologies and services, indicating the trust's strategy to capitalize on growth opportunities within this dynamic industry.

In terms of performance metrics, the filing disclosed that the fund experienced a monthly total return of 10.96% for the reporting period, which may attract further interest from potential investors. The fund's investment strategy appears to be yielding positive results, as evidenced by the reported returns.

The filing may influence various stakeholders, including current investors, potential investors, and market analysts. By providing a detailed overview of its financial status, Tema ETF Trust aims to bolster investor confidence and maintain transparency in its operations. The healthcare sector, characterized by rapid innovation and growth, remains a focal point for the trust, which could lead to further investment opportunities.

As for future developments, the filing does not specify any immediate actions or upcoming events related to the fund. However, the trust's ongoing commitment to regulatory compliance and transparency suggests that additional filings may be forthcoming as it continues to navigate the investment landscape.